// COMPANY
Onward Therapeutics
SECTOR BIOTECHMENTIONS 1LAST SEEN NOVEMBER 19, 2026
// OVERVIEW
Taiwan-based biotech company.
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·PitchBook News·NOVEMBER 19, 2026
“raised a 900 million New Taiwan dollar ($28 million) Series B”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.